Micro Bird Buy Adds EBITDA, But Organic Core Remains Tepid

What happened

Blue Bird acquired the remaining 50% of Micro Bird for $201.8 million at a 10.7x FY2026 EBITDA multiple, below the sector median of 12.3x. The deal underpins an 8.9% EBITDA guidance raise, but only 2.2% of that is organic, signaling underlying demand is softer than headline numbers imply. Management’s 14-quarter beat streak adds credibility to midterm targets, yet the acquisition does nothing to resolve the core tariff pass-through and backlog uncertainty that define the next 6–9 months. The DeepValue analysis maintains a WAIT rating, with the base case $62 already pricing in tariff-neutral margins and stable backlog through June 2026. Until gross margin retention and post-June 2026 order resilience become visible, risk-reward favors waiting for a pullback toward the $52 buyback zone.

Implication

The deal valuation (10.7x EBITDA) looks cheap relative to peers, but the organic EBITDA raise of only 2.2% highlights that core bus demand is not accelerating. Management's beat track record supports updated targets, but the focus should remain on whether pricing can sustain margins after the June 2026 tariff lock expires. The DeepValue base case of $62 embeds continued tariff-neutral margins and stable backlog; any deterioration pushes the stock toward the $45 bear case. Monitor Q2 and Q3 FY2026 gross margins and backlog trends as key leading indicators. We recommend waiting for a pullback toward $52 or clearer evidence of demand durability beyond the current pricing window before adding.

Thesis delta

The acquisition adds near-term EBITDA visibility but does not alter the core thesis that Blue Bird's valuation hinges on tariff pass-through and backlog stability; organic growth remains soft, reinforcing the WAIT stance.